2022 Genitourinary Cancers Symposium
The 2022 Genitourinary Cancers Symposium publication includes articles and expert perspectives on the groundbreaking data presented at the 2022 Genitourinary Cancers Symposium in San Francisco, California.
Volume: 01
Issue: 01
2021 ESMO Congress: Genitourinary Cancers
The 2021 ESMO Congress priority report focuses on updates in genitourinary cancers presented at the virtual conference, held September 16 to 21, 2021.
Volume: 1
Issue: 1
ASCO 2021: Updates in Genitourinary Cancers
This publication provides coverage of data in genitourinary cancers that were presented at the 2021 ASCO Annual Meeting.
2021 Genitourinary Cancers Symposium
Volume: 02
ASCO 2020: Update on Genitourinary Cancers
2020 Genitourinary Cancers Symposium
Dr Liu Previews ASCO 2024 Lung Cancer Data
Dr Rajkumar Previews ASCO 2024 Data in Multiple Myeloma
Ribociclib Plus NSAI Maintains Manageable Safety Profile in HR+/HER2– Early Breast Cancer
Novel CDK4 Inhibitor Shows Activity and Safety in HR+/HER2– Metastatic Breast Cancer